Literature DB >> 28586095

CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.

Nandini Makwana1,2, Bree Foley3, Sonia Fernandez1, Silvia Lee2,4, Ashley Irish5,6, Hanspeter Pircher7, Patricia Price2,8.   

Abstract

Cytomegalovirus (CMV) is a common opportunistic infection encountered in renal transplant recipients (RTRs) and may be reactivated without symptoms at any time post-transplant. We describe how active and latent CMV affect T-cell subsets in RTRs who are stable on maintenance therapy. T-cell responses to CMV were assessed in RTRs (n = 54) >2 years post-transplant, and healthy controls (n = 38). Seven RTRs had CMV DNA detectable in plasma. CMV antibody and DNA aligned with increased proportions of CD8+ T cells and reduced CD4/CD8 ratios. This paralleled an expansion of effector memory T-cell (TEM ), terminally differentiated T-cell (TEMRA ) and CD57+ TEMRA cell populations. Expression of NK-cell receptors, LIR-1 and KLRG1 on CD4+ and CD8+ CD57+ TEM and TEMRA cells correlated with elevated interferon-γ and cytotoxic responses to anti-CD3 and increased cytotoxic responses to CMV phosphoprotein (pp) 65 in RTRs who carried CMV DNA. CD8+ T cells from all CMV seropositive RTRs responded efficiently to CMV immediate early (IE) -1 peptides. The data show that latent and active CMV infection can alter T-cell subsets in RTRs many years after transplantation, and up-regulate T-cell expression of NK-cell receptors. This may enhance effector responses of CD4+ and CD8+ T cells against CMV.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cytomegalovirus · NK-cell receptors · Renal transplantation · T cells

Mesh:

Substances:

Year:  2017        PMID: 28586095     DOI: 10.1002/eji.201747018

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Functional Consequences of Memory Inflation after Solid Organ Transplantation.

Authors:  Lauren E Higdon; Steven Schaffert; Rachel H Cohen; Maria E Montez-Rath; Marc Lucia; Naresha Saligrama; Kenneth B Margulies; Olivia M Martinez; Jane C Tan; Mark M Davis; Purvesh Khatri; Jonathan S Maltzman
Journal:  J Immunol       Date:  2021-09-22       Impact factor: 5.426

2.  mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation.

Authors:  Hannah Kaminski; Gabriel Marseres; Nathalie Yared; Marie-Julie Nokin; Vincent Pitard; Atika Zouine; Isabelle Garrigue; Séverine Loizon; Myriam Capone; Xavier Gauthereau; Maria Mamani-Matsuda; Roxane Coueron; Raúl V Durán; Benoît Pinson; Isabelle Pellegrin; Rodolphe Thiébaut; Lionel Couzi; Pierre Merville; Julie Déchanet-Merville
Journal:  J Am Soc Nephrol       Date:  2021-11-01       Impact factor: 10.121

3.  Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Authors:  Birgit Sawitzki; Paul N Harden; Petra Reinke; Aurélie Moreau; James A Hutchinson; David S Game; Qizhi Tang; Eva C Guinan; Manuela Battaglia; William J Burlingham; Ian S D Roberts; Mathias Streitz; Régis Josien; Carsten A Böger; Cristiano Scottà; James F Markmann; Joanna L Hester; Karsten Juerchott; Cecile Braudeau; Ben James; Laura Contreras-Ruiz; Jeroen B van der Net; Tobias Bergler; Rossana Caldara; William Petchey; Matthias Edinger; Nathalie Dupas; Michael Kapinsky; Ingrid Mutzbauer; Natalie M Otto; Robert Öllinger; Maria P Hernandez-Fuentes; Fadi Issa; Norbert Ahrens; Christoph Meyenberg; Sandra Karitzky; Ulrich Kunzendorf; Stuart J Knechtle; Josep Grinyó; Peter J Morris; Leslie Brent; Andrew Bushell; Laurence A Turka; Jeffrey A Bluestone; Robert I Lechler; Hans J Schlitt; Maria C Cuturi; Stephan Schlickeiser; Peter J Friend; Tewfik Miloud; Alexander Scheffold; Antonio Secchi; Kerry Crisalli; Sang-Mo Kang; Rachel Hilton; Bernhard Banas; Gilles Blancho; Hans-Dieter Volk; Giovanna Lombardi; Kathryn J Wood; Edward K Geissler
Journal:  Lancet       Date:  2020-05-23       Impact factor: 202.731

4.  Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4+ memory T cells.

Authors:  Kim-Long Truong; Stephan Schlickeiser; Katrin Vogt; David Boës; Katarina Stanko; Christine Appelt; Mathias Streitz; Gerald Grütz; Nadja Stobutzki; Christian Meisel; Christina Iwert; Stefan Tomiuk; Julia K Polansky; Andreas Pascher; Nina Babel; Ulrik Stervbo; Igor Sauer; Undine Gerlach; Birgit Sawitzki
Journal:  Nat Commun       Date:  2019-05-22       Impact factor: 14.919

Review 5.  Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.

Authors:  Mi Deng; Heyu Chen; Xiaoye Liu; Ryan Huang; Yubo He; Byounggyu Yoo; Jingjing Xie; Samuel John; Ningyan Zhang; Zhiqiang An; Cheng Cheng Zhang
Journal:  Antib Ther       Date:  2021-02-09

6.  CMV Status Drives Distinct Trajectories of CD4+ T Cell Differentiation.

Authors:  Weiwen Zhang; Anna B Morris; Erica V Peek; Geeta Karadkhele; Jennifer M Robertson; Haydn T Kissick; Christian P Larsen
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

7.  Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis.

Authors:  James A Hutchinson; Katharina Kronenberg; Paloma Riquelme; Jürgen J Wenzel; Gunther Glehr; Hannah-Lou Schilling; Florian Zeman; Katja Evert; Martin Schmiedel; Marion Mickler; Konstantin Drexler; Florian Bitterer; Laura Cordero; Lukas Beyer; Christian Bach; Josef Koestler; Ralph Burkhardt; Hans J Schlitt; Dirk Hellwig; Jens M Werner; Rainer Spang; Barbara Schmidt; Edward K Geissler; Sebastian Haferkamp
Journal:  Nat Commun       Date:  2021-03-04       Impact factor: 14.919

8.  Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells.

Authors:  Kornelis S M van der Geest; Bart-Jan Kroesen; Gerda Horst; Wayel H Abdulahad; Elisabeth Brouwer; Annemieke M H Boots
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

9.  CD56+CD57+ infiltrates as the most predominant subset of intragraft natural killer cells in renal transplant biopsies with antibody-mediated rejection.

Authors:  Hey Rim Jung; Mi Joung Kim; Yu-Mee Wee; Jee Yeon Kim; Monica Young Choi; Ji Yoon Choi; Hyunwook Kwon; Joo Hee Jung; Yong Mee Cho; Heounjeong Go; Sang-Yeob Kim; Yeon-Mi Ryu; Yun Jae Kim; Young Hoon Kim; Duck Jong Han; Sung Shin
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.